Skip to main content

Table 1 Comparison of patients characteristics according to the sickle genotypes

From: High fetal hemoglobin level is associated with increased risk of cerebral vasculopathy in children with sickle cell disease in Mayotte

 

SS (n = 118)

Sbeta° (n = 26)

Sbeta+ (n = 19)

P

Mean (±SD) or n (%)

Hb (g/dL)

7,8 (±0,1)

8,3 (±0,3)

8,8 (±0,1)

 

Hematocrit (%)

24,1 (±0,3)

27,0 (±0,7)

28,3 (±1,0)

 

MCV (fL)

80,3 (±0,9)

65,8 (±1,3)

69,3 (±2,2)

 

MCHC (g/dL)

32,7 (±0,1)

31,0 (±0,3)

31,7 (±0,3)

 

Reticulocytes (G/L)

268,1 (±9,8)

250,0 (±20,9)

179,1 (±19,0)

0,003

Leukocytes (G/L)

13,2 (±0,4)

10,6 (±0,7)

11,0 (±0,7)

0,007

Hospitalization/year

   

0,003

No

13 (11,1)

8 (32)

7 (38,9)

 

1 to 2

91 (77,8)

17 (68)

11 (61,1)

 

≥ 3

13 (11,1)

0

0

 

Red Blood Cell Transfusion érythrocytaire

   

0,001

Never

20 (17,1)

13 (52)

8 (42,1)

 

Occasionnally

78 (66,7)

11 (44)

11 (57,9)

 

Transfusion therapy

19 (16,2)

1 (4)

0

 

Infection

61 (55)

8 (30,8)

6 (31,6)

0,026

Acute Chest Syndrome

27 (23,9)

0

4 (21,1)

0,009

Number of ACS/year

   

0,041

Never

80 (74,1)

25 (100)

15 (78,9)

 

1

22 (20,4)

0

3 (15,8)

 

≥ 2

6 (5,5)

0

1 (5,3)

 

Cholelithiasis

28 (26,4)

4 (18,2)

0

0,038